Stanford inventors have developed a cell-free method for carbon-negative biosynthetic production of commodity biochemicals by using hydrogen gas as a source of reducing equivalents.
Researchers in Prof. Hemamala Karunadasa's laboratory have developed inexpensive, robust, high capacity hybrid materials for reversible or irreversible capture of halogens (chlorine, bromine, and iodine gas).